% alzhub.org library filter % Source: https://alzhub.org/research?score_min=67&atag=repurposing % 9 entries, in the order the page lists them. Built from alzhub.org's own records. % 0 entries have no readable author in the source record and carry no author field. @article{hua2022-35180125, author = {Hua, Xue and Church, Kevin and Walker, William and L'Hostis, Philippe and Viardot, Geoffrey and Danjou, Philippe and Hendrix, Suzanne and Moebius, Hans J}, title = {{Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Positive Modulator of HGF/MET, Fosgonimeton, in Healthy Volunteers and Subjects with Alzheimer's Disease: Randomized, Placebo-Controlled, Double-Blind, Phase I Clinical Trial}}, journal = {Journal of Alzheimer's disease : JAD}, year = {2022}, doi = {10.3233/jad-215511}, pmid = {35180125}, url = {https://doi.org/10.3233/jad-215511} } @article{wang2020-32928279, author = {Wang, Tao and Kuang, Weihong and Chen, Wei and Xu, Wenwei and Zhang, Liming and Li, Yingjie and Li, Hailin and Peng, Ying and others}, title = {{A phase II randomized trial of sodium oligomannate in Alzheimer's dementia}}, journal = {Alzheimer's research \& therapy}, year = {2020}, doi = {10.1186/s13195-020-00678-3}, pmid = {32928279}, url = {https://doi.org/10.1186/s13195-020-00678-3} } @article{nordberg2009-19199870, author = {Nordberg, Agneta and Darreh-Shori, Taher and Peskind, Elaine and Soininen, Hilkka and Mousavi, Malahat and Eagle, Gina and Lane, Roger}, title = {{Different cholinesterase inhibitor effects on CSF cholinesterases in Alzheimer patients}}, journal = {Current Alzheimer research}, year = {2009}, doi = {10.2174/156720509787313961}, pmid = {19199870}, url = {https://doi.org/10.2174/156720509787313961} } @article{faux2010-20164561, author = {Faux, N. G. and Ritchie, C. W. and Gunn, A. and Rembach, A. and Tsatsanis, A. and Bedo, J. and Harrison, J. and Lannfelt, L. and others}, title = {{PBT2 rapidly improves cognition in Alzheimer's Disease: additional phase II analyses}}, journal = {Journal of Alzheimer's disease : JAD}, year = {2010}, doi = {10.3233/jad-2010-1390}, pmid = {20164561}, url = {https://doi.org/10.3233/jad-2010-1390} } @article{jang2022-36440278, author = {Jang, Ha Young and Oh, Jung Mi and Kim, In-Wha}, title = {{Drug repurposing using meta-analysis of gene expression in Alzheimer's disease}}, journal = {Frontiers in neuroscience}, year = {2022}, doi = {10.3389/fnins.2022.989174}, pmid = {36440278}, url = {https://doi.org/10.3389/fnins.2022.989174} } @article{bourdakou2023-37696195, author = {Bourdakou, Marilena M and Fernández-Ginés, Raquel and Cuadrado, Antonio and Spyrou, George M}, title = {{Drug repurposing on Alzheimer's disease through modulation of NRF2 neighborhood}}, journal = {Redox biology}, year = {2023}, doi = {10.1016/j.redox.2023.102881}, pmid = {37696195}, url = {https://doi.org/10.1016/j.redox.2023.102881} } @article{vanderoovaart2023-38004378, author = {Van de Roovaart, Hannah J and Nguyen, Nguyen and Veenstra, Timothy D}, title = {{Huntington's Disease Drug Development: A Phase 3 Pipeline Analysis}}, journal = {Pharmaceuticals (Basel, Switzerland)}, year = {2023}, doi = {10.3390/ph16111513}, pmid = {38004378}, url = {https://doi.org/10.3390/ph16111513} } @article{flicker1994-8267111, author = {Flicker, C and Ferris, S H and Kalkstein, D and Serby, M}, title = {{A double-blind, placebo-controlled crossover study of ganglioside GM1 treatment for Alzheimer's disease}}, journal = {The American journal of psychiatry}, year = {1994}, doi = {10.1176/ajp.151.1.126}, pmid = {8267111}, url = {https://doi.org/10.1176/ajp.151.1.126} } @article{fonsecasantos2015-26345528, author = {Fonseca-Santos, B. and Gremião, M. P. and Chorilli, M.}, title = {{Nanotechnology-based drug delivery systems for the treatment of Alzheimer's disease}}, journal = {International journal of nanomedicine}, year = {2015}, doi = {10.2147/ijn.s87148}, pmid = {26345528}, url = {https://doi.org/10.2147/ijn.s87148} }